M. Denijn
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
-
- Protease and Inhibitor Mechanisms
Papers in
-
- S100 Proteins and Annexins 3
- Angiogenesis and VEGF in Cancer 2
- Signaling Pathways in Disease 1
- Oncology 5
- Peptidase Inhibition and Analysis 2
- Co-authors
- D. J. Ruiter (3 shared papers)Hein W. Verspaget (1 shared paper)Kiek Verrijp (1 shared paper)Jan H. Verheijen (1 shared paper)Paul H.A. Quax (1 shared paper)Ulrich H. Weidle (1 shared paper)T. J. de Vries (1 shared paper)G N van Muijen (1 shared paper)
- Journals
- Journal of Histochemistry & Cytochemistry (2 papers)Apmis (1 paper)Melanoma Research (1 paper)The Journal of Pathology (1 paper)Histochemistry and Cell Biology (1 paper)
- Partner nations
- Netherlands
In The Last Decade
M. Denijn
10 papers receiving 357 citations
Peers
Comparison fields: 5 of 64
- Immunology and Allergy 97
- Cancer Research 120
- Oncology 117
- Cell Biology 61
- Immunology 78
Countries citing papers authored by M. Denijn
This map shows the geographic impact of M. Denijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Denijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Denijn more than expected).
Fields of papers citing papers by M. Denijn
This network shows the impact of papers produced by M. Denijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Denijn. The network helps show where M. Denijn may publish in the future.
Co-authors
The 22 scholars most cited alongside M. Denijn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. | 1994 | 133 |
| 2 | Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. | 1993 | 87 |
| 3 | Angiogenesis in wound healing and tumor metastasis. | 1993 | 48 |
| 4 | 1993 | 45 | |
| 5 | 1990 | 28 | |
| 6 | 1992 | 11 | |
| 7 | 1992 | 10 | |
| 8 | 1992 | 5 | |
| 9 | 1993 | 5 | |
| 10 | Hybridohistochemical demonstration of alternative splicing of the CALC-I gene. | 1991 | 4 |
About M. Denijn
M. Denijn is a scholar working on Molecular Biology, Oncology, Surgery, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism, having authored 10 papers that have together received 376 indexed citations. Recurring topics across this work include S100 Proteins and Annexins (3 papers), Angiogenesis and VEGF in Cancer (2 papers), Neuropeptides and Animal Physiology (2 papers), Cell Adhesion Molecules Research (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Peptidase Inhibition and Analysis (2 papers), Pancreatic function and diabetes (1 paper) and Signaling Pathways in Disease (1 paper). The work is most often cited by research in Immunology and Allergy (97 citations), Cancer Research (120 citations), Oncology (117 citations), Cell Biology (61 citations) and Immunology (78 citations). M. Denijn has collaborated with scholars based in Netherlands. Frequent co-authors include D. J. Ruiter, Hein W. Verspaget, Kiek Verrijp, Jan H. Verheijen, Paul H.A. Quax, Ulrich H. Weidle, T. J. de Vries, G N van Muijen, Roel A. de Weger and Arthur Vogel. Their work appears in journals such as Journal of Histochemistry & Cytochemistry, Apmis, Melanoma Research, The Journal of Pathology and Histochemistry and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.